Rhonda Farnum, SVP, COMM & MEDICAL AFFAIRS at Theravance Biopharma, Inc. (TBPH), sold 19,473 shares at $8.71 ($173K) on 2024-02-22, disclosed to the SEC on 2024-02-22.
Scheduled sale ($173k) by SVP, COMM & MEDICAL AFFAIRS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.92 | 18,219 | $163K | 93.7% |
| 2 | $8.71 | 1,254 | $11K | 6.3% |
| Total | $8.91 avg | 19,473 | $173K | 100% |
| Filing → |
| TBPH | SELL | 2026-03-18 | $650K | — | Filing → |
| TBPH | SELL | 2025-12-05 | $1.2M | — | Filing → |
| TBPH | SELL | 2025-07-16 | $174K | — | Filing → |